Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
904409622 | 9044096 | 22 | F | 201101 | 20160919 | 20130130 | 20160928 | EXP | PHHY2013CA007594 | NOVARTIS | 60.56 | YR | F | Y | 0.00000 | 20160928 | CN | COUNTRY NOT SPECIFIED | CA |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
904409622 | 9044096 | 1 | PS | GLEEVEC | IMATINIB MESYLATE | 1 | Oral | 400 MG, QD | 21588 | 400 | MG | TABLET | QD | ||||||
904409622 | 9044096 | 2 | SS | GLEEVEC | IMATINIB MESYLATE | 1 | Oral | 400 MG, QD | 21588 | 400 | MG | TABLET | QD | ||||||
904409622 | 9044096 | 3 | SS | GLEEVEC | IMATINIB MESYLATE | 1 | Oral | 400 MG, QD | 21588 | 400 | MG | TABLET | QD | ||||||
904409622 | 9044096 | 4 | C | LOSEC | OMEPRAZOLE | 1 | Unknown | UNK | 0 | ||||||||||
904409622 | 9044096 | 5 | C | LOSEC | OMEPRAZOLE | 1 | Unknown | UNK | 0 | ||||||||||
904409622 | 9044096 | 6 | C | VITAMIN B12 | CYANOCOBALAMIN | 1 | Unknown | UNK UNK, QMO | U | 0 | INJECTION | /month | |||||||
904409622 | 9044096 | 7 | C | APO-OMEPRAZOLE | OMEPRAZOLE | 1 | Unknown | 20 MG, UNK | Y | 0 | 20 | MG | |||||||
904409622 | 9044096 | 8 | C | APO-HYDROCHLOROTHIAZIDE | 2 | Unknown | Y | 0 |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
904409622 | 9044096 | 1 | Chronic myeloid leukaemia |
904409622 | 9044096 | 4 | Product used for unknown indication |
904409622 | 9044096 | 6 | Product used for unknown indication |
904409622 | 9044096 | 7 | Product used for unknown indication |
904409622 | 9044096 | 8 | Hypertension |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
904409622 | 9044096 | HO |
904409622 | 9044096 | OT |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
904409622 | 9044096 | Abdominal abscess | |
904409622 | 9044096 | Abdominal discomfort | |
904409622 | 9044096 | Abdominal sepsis | |
904409622 | 9044096 | Blood pressure decreased | |
904409622 | 9044096 | Blood test abnormal | |
904409622 | 9044096 | Burning sensation | |
904409622 | 9044096 | Chills | |
904409622 | 9044096 | Diarrhoea | |
904409622 | 9044096 | Diarrhoea haemorrhagic | |
904409622 | 9044096 | Dysgeusia | |
904409622 | 9044096 | Dyspnoea | |
904409622 | 9044096 | Eye swelling | |
904409622 | 9044096 | Fistula | |
904409622 | 9044096 | Gastroenteritis viral | |
904409622 | 9044096 | Genital haemorrhage | |
904409622 | 9044096 | Haemorrhage | |
904409622 | 9044096 | Herpes zoster | |
904409622 | 9044096 | Hot flush | |
904409622 | 9044096 | Hyperhidrosis | |
904409622 | 9044096 | Hypersensitivity | |
904409622 | 9044096 | Infection | |
904409622 | 9044096 | Influenza | |
904409622 | 9044096 | Malaise | |
904409622 | 9044096 | Muscle spasms | |
904409622 | 9044096 | Nausea | |
904409622 | 9044096 | Night sweats | |
904409622 | 9044096 | Paraesthesia | |
904409622 | 9044096 | Pneumonia | |
904409622 | 9044096 | Rash generalised | |
904409622 | 9044096 | Temperature intolerance | |
904409622 | 9044096 | Vomiting | |
904409622 | 9044096 | Weight decreased |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
---|---|---|---|---|---|---|
904409622 | 9044096 | 1 | 20101230 | 201101 | 0 | |
904409622 | 9044096 | 2 | 201102 | 0 | ||
904409622 | 9044096 | 3 | 201103 | 0 |